Solid Biosciences Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Solid Biosciences Inc. (SLDB) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 6.72 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 6.72M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 6.13M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 4.38M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 4.38M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2026-06-30 | 6.72M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 6.13M shares 10-Q · filed 2026-05-12 |
| 2025-12-31 | 4.38M shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 4.38M shares 10-Q · filed 2025-11-03 |
| 2025-06-30 | 3.32M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 2.85M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 2.93M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 2.94M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 2.89M shares 10-Q · filed 2024-08-13 |
| 2023-12-31 | 2.26M shares 10-K · filed 2024-03-13 |
| 2022-12-31 | 1.43M shares 10-K · filed 2023-03-23 |
| 2021-12-31 | 6.01M shares 10-K · filed 2022-03-14 |
| 2020-12-31 | 3.12M shares 10-K · filed 2021-03-15 |
| 2019-12-31 | 2.61M shares 10-K · filed 2020-03-12 |
| 2018-12-31 | 1.15M shares 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |